HumaninLongevity
Mitochondrial-derived peptide studied for cytoprotection and longevity.
Overview
Humanin is a short peptide encoded in mitochondrial DNA — one of the first "mitochondrial-derived peptides", discovered in 2001 in a screen for factors that protect neurons against Alzheimer's-related insults. It has since been researched for cell protection, insulin sensitivity and aging, but that work is cell and animal studies; in people, research has only measured the body's own humanin levels. No human trial of administered humanin has been published. It is not FDA-evaluated and is sold for laboratory research only; nothing here is medical or dosing advice.
Evidence
Anecdotal reports community-reported
What people describe in forums, blogs and uncontrolled clinic write-ups — experiential and unverified, not clinical evidence and not medical advice.
- Energy; several prefer it to MOTS-ca sizeable minority
Among the few who say they have run both, a recurring verdict is that humanin gave more noticeable energy than MOTS-c, and one calls it under-rated next to the attention MOTS-c gets. None of these reports gives a dose or duration, and one adds that they have never found humanin that tests well, so product identity is a confounder.
- Sleep and calmoccasionally reported
One user on 2 mg every other day says that after the second dose they slept a solid eight hours instead of waking one to three times a night, though they had been dosing for only a week and have post-Lyme neurological issues. Another co-injecting 5 mg humanin with 5 mg MOTS-c every 4–5 days noticed no difference from MOTS-c alone, and credits better sleep partly to epitalon taken at the same time.
- No perceptible effectcommonly reported
The commonest answer to 'what did humanin do' is nothing perceptible in the short or medium term; users who keep taking it describe it as a bet on healthspan or a counterweight to growth-hormone use rather than something felt. A single 500 mcg dose gave one user a drop in anxiety they themselves attribute to possible placebo. Others bought vials and never used them because no dosing protocol exists.
- Reported doses are all over the placecommonly reported
Figures quoted range from 25–50 mcg daily (traced to one older post) through 100–200 mcg once or twice daily, 1 mg/day for 30 days inside a MOTS-c cycle, 2 mg every other day, up to 5 mg once a week paired with MOTS-c on other days. A user who received a 150 mg vial asked how to split it and was told not to sacrifice sterility; the only published protocol anyone cites is a rat cardiac study of the HNG analogue.
- Where it sits in the SS-31 / MOTS-c sequencecommonly reported
Humanin is almost always discussed as the optional third leg of a mitochondrial stack: a typical plan is SS-31 first, then MOTS-c, with a month of humanin added during or after the MOTS-c run and omitted if money is tight. Users admit the sequence is reasoning, not literature. A few flag that humanin lowers IGF-1 and prefer to run it only in a growth-hormone off-cycle.
- Skepticism and cautionsa sizeable minority
Skeptics say humanin has little research at all and that cheaper, better-studied AMPK agents cover the same pathway; one longevity reader points out that high humanin in centenarians may be a marker, not a cause. Replies to a favourable write-up cite a paper in which humanin promoted tumour progression in a breast-cancer model and ask people to weigh that before use.
Sources
Starting references for the library summary. These are not dosing instructions or medical advice.
Prices
Compare Humanin prices across vendors.
Compare prices — from $165.00For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.